Search

Author/Creator Eggermont, Alexander MM.

1. Crossover and rechallenge with pembrolizumab in recurrent patients from the EORTC 1325-MG/Keynote-054 phase III trial, pembrolizumab versus placebo after complete resection of high-risk stage III melanoma. (November 2021)

Authors:
Eggermont, Alexander MM.; Meshcheryakov, Andrey; Atkinson, Victoria; Blank, Christian U.; Mandala, Mario; Long, Georgina V.; Barrow, Catherine; Di Giacomo, Anna Maria; Fisher, Rosalie; Sandhu, Shahneen; Kudchadkar, Ragini; Ortiz Romero, Pablo Luis; Svane, Inge Marie; Larkin, James; Puig, Susana; ...
Journal:
European journal of cancer
Issue:
Volume 158(2021)
Page Start:
156
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Interpreting European Organisation for Research and Treatment for Cancer Quality of life Questionnaire core 30 scores as minimally importantly different for patients with malignant melanoma. (November 2018)

Authors:
Musoro, Jammbe Z.; Bottomley, Andrew; Coens, Corneel; Eggermont, Alexander MM.; King, Madeleine T.; Cocks, Kim; Sprangers, Mirjam AG.; Groenvold, Mogens; Velikova, Galina; Flechtner, Hans-Henning; Brandberg, Yvonne
Journal:
European journal of cancer
Issue:
Volume 104(2018)
Page Start:
169
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search